---
title: "BioCardia Inc. CEO Peter Altman Reports Acquisition of Common Shares"
description: "Peter Altman, CEO of BioCardia Inc., announced the acquisition of common shares of the company. The full filing is available through the provided link. This news was generated by Public Technologies a"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/254463703.md"
published_at: "2025-08-25T13:30:51.000Z"
---

# BioCardia Inc. CEO Peter Altman Reports Acquisition of Common Shares

> Peter Altman, CEO of BioCardia Inc., announced the acquisition of common shares of the company. The full filing is available through the provided link. This news was generated by Public Technologies and is for informational purposes only, not to be considered as financial or legal advice. The original content was published via EDGAR on August 25, 2025.

Peter Altman, President and CEO of BioCardia Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCardia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-027633), on August 25, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [BCDA.US - BioCardia](https://longbridge.com/en/quote/BCDA.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| BioCardia 為 Helix™提交了 FDA 批准的預提交文件 | BioCardia Inc：BioCardia 提交了 Helix™ 經心內膜輸送導管的預提交申請，以獲得 FDA 對心臟治療和診斷藥物輸送的批准 | [Link](https://longbridge.com/en/news/275481248.md) |
| BioCardia 展示了 CardiAMP-HF 研究中的新超聲心動圖數據 | BioCardia Inc. 宣佈，心力衰竭細胞治療的 CardiAMP HF 臨牀試驗的新超聲心動圖結果已被接受，在技術與心力衰竭治療會議（THT Meeting）上進行晚期臨牀試驗口頭報告。該報告題為 “自體細胞治療可能抑制慢性缺血性  | [Link](https://longbridge.com/en/news/274660260.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
